{
    "2021-07-12": [
        [
            {
                "time": "",
                "orginal_text": "上半年，药企中8位董事长已离职 董监高成员变化",
                "features": {
                    "keywords": [
                        "药企",
                        "董事长",
                        "离职",
                        "董监高"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "万泰生物：股东赵义勇减持19万股，减持计划时间已过半",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "股东",
                        "赵义勇",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "万泰生物(603392.SH)财务总监赵义勇累计减持18.72万股 减持计划时间已过半",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "财务总监",
                        "赵义勇",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业：十四五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "十四五",
                        "血制品",
                        "天坛生物",
                        "博雅生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "上半年百位药企高管离职，8位为董事长级别",
                "features": {
                    "keywords": [
                        "药企",
                        "高管",
                        "离职",
                        "董事长"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}